Mucormycosis is a rare but fatal, invasive opportunistic fungal infection generally described among immunocompromised individuals. The ongoing pandemic coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 has severely compromised the immune system of patients thereby making them vulnerable to mucormycosis, especially when they are lined up with associated comorbidities. Here, we present a case of one such 64-year-old male patient being on corticosteroids and a case of long-standing diabetes mellitus and chronic kidney disease. COVID-19 triggered the mucormycosis in this patient thereby leading to a condition we have described as rhino-orbital pulmonary mucormycosis.
{"title":"A case of COVID-19 triggered Rhino-Orbital Pulmonary Mucormycosis in Central India","authors":"Chandra Singh Rathore, Shirin Ansari, T. Bajpai","doi":"10.4103/bmrj.bmrj_8_21","DOIUrl":"https://doi.org/10.4103/bmrj.bmrj_8_21","url":null,"abstract":"Mucormycosis is a rare but fatal, invasive opportunistic fungal infection generally described among immunocompromised individuals. The ongoing pandemic coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 has severely compromised the immune system of patients thereby making them vulnerable to mucormycosis, especially when they are lined up with associated comorbidities. Here, we present a case of one such 64-year-old male patient being on corticosteroids and a case of long-standing diabetes mellitus and chronic kidney disease. COVID-19 triggered the mucormycosis in this patient thereby leading to a condition we have described as rhino-orbital pulmonary mucormycosis.","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"121 1","pages":"25 - 28"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89386405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Robinson, Olukumni Ijeruh, W. Wonodi, Rufus Abam
Introduction: Clinical governance in radiology is an improved quality assurance program where the patient well-being is the central focus concerning radiologic service using the radiology request form (RRF). Methodology: The study was a 6-month descriptive study conducted from January 2020 to June 2020. A total of 2053 request forms were collated retrospectively and evaluated to ascertain the appropriateness of the clinical information with the investigation requested. A 3 stage Likert scale of appropriate somewhat appropriate and inappropriate was used and the data analyzed using the statistical package for the social sciences (SPSS) IBM Corp. version 23.0 (Armonk, NY: USA). The results were expressed in percentages and frequencies and presented in tables and charts. Results: Of the 2053 request forms, X-rays constitute 32.54% while ultrasound scans and computed tomography (CT) investigations constitute 43.21% and 5.46%, respectively. Clinical information was indicated in 51.39% of the RRF, out of which 75.95% of the clinical information were adequate while 13.93% were not in keeping with the investigation. Ultrasound scan request had the highest inappropriate clinical information (54.68%) followed by plain radiography request (41.73%) whereas all the CT request was in tandem with the investigation. Conclusion: There are occasional clinical information and radiologic request mismatch. This may be due to the filling of the RRF by medical interns or nonmedical personnel such as allied health workers with less knowledge on radiologic imaging modalities. The audit recommends proper supervision of young clinicians and continues medical education concerning the rational use of imaging modality.
简介:放射学的临床管理是一个改进的质量保证计划，其中患者的福祉是使用放射学申请表(RRF)的放射服务的中心焦点。方法:该研究是一项为期6个月的描述性研究，于2020年1月至2020年6月进行。回顾性整理和评估共2053份申请表，以确定临床信息与所要求的调查的适当性。使用适当和不适当的3阶段李克特量表，并使用社会科学统计软件包(SPSS) IBM Corp. version 23.0 (Armonk, NY: USA)对数据进行分析。结果以百分比和频率表示，并以表格和图表形式呈现。结果:2053份申请单中，x线占32.54%，超声和CT检查分别占43.21%和5.46%。51.39%的RRF有临床信息，其中75.95%的临床信息是充分的，13.93%的临床信息与调查不一致。超声扫描请求中临床信息不恰当的比例最高(54.68%)，其次是x线平片请求(41.73%)，而所有CT请求均与调查一致。结论:偶有临床资料与影像学要求不匹配的情况。这可能是由于填补RRF的是医疗实习生或非医疗人员，如对放射成像模式了解较少的专职卫生工作者。审计建议对年轻临床医生进行适当监督，并继续进行有关合理使用成像方式的医学教育。
{"title":"Clinical governance in radiologic practice: Evaluating the appropriateness of radiologic investigation considering patient clinical information using the radiology request form","authors":"E. Robinson, Olukumni Ijeruh, W. Wonodi, Rufus Abam","doi":"10.4103/bmrj.bmrj_19_20","DOIUrl":"https://doi.org/10.4103/bmrj.bmrj_19_20","url":null,"abstract":"Introduction: Clinical governance in radiology is an improved quality assurance program where the patient well-being is the central focus concerning radiologic service using the radiology request form (RRF). Methodology: The study was a 6-month descriptive study conducted from January 2020 to June 2020. A total of 2053 request forms were collated retrospectively and evaluated to ascertain the appropriateness of the clinical information with the investigation requested. A 3 stage Likert scale of appropriate somewhat appropriate and inappropriate was used and the data analyzed using the statistical package for the social sciences (SPSS) IBM Corp. version 23.0 (Armonk, NY: USA). The results were expressed in percentages and frequencies and presented in tables and charts. Results: Of the 2053 request forms, X-rays constitute 32.54% while ultrasound scans and computed tomography (CT) investigations constitute 43.21% and 5.46%, respectively. Clinical information was indicated in 51.39% of the RRF, out of which 75.95% of the clinical information were adequate while 13.93% were not in keeping with the investigation. Ultrasound scan request had the highest inappropriate clinical information (54.68%) followed by plain radiography request (41.73%) whereas all the CT request was in tandem with the investigation. Conclusion: There are occasional clinical information and radiologic request mismatch. This may be due to the filling of the RRF by medical interns or nonmedical personnel such as allied health workers with less knowledge on radiologic imaging modalities. The audit recommends proper supervision of young clinicians and continues medical education concerning the rational use of imaging modality.","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"44 1","pages":"20 - 24"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83046989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The thermal changes in environments that composite materials are exposed to has a great effect on fatigue and wear behavior. Aim: Micro-cracks and interfacial deformations occur in the composite material structure because of heating and cooling environments occurring on material surfaces. Considering the environment to which bio-composite materials used in the human body are exposed, it is inevitable that they are exposed to a thermal change cycle environment. Material and Method: In this study, the mechanical behaviors of Silorane, X-Trafil and Valux-Plus bio-composite materials were examined after being exposed to thermal cycles in an artificial mouth environment in the temperature range of minimum 5 °C and maximum 65 °C. Micro-tensile strengths of bio-composite materials after thermal cycle test procedures were determined using a universal micro tensile tester device. In addition, microstructural analyzes of bio-composite materials were evaluated using scanning electron microscopy (SEM). Results: Within the scope of the data obtained as a result of this study, it was concluded that the thermal changes in environments significantly affects the micro-shrinkage behavior of bio-composite materials. Conclusion: The behavior of the matrix structure of the composite material significantly affected the formation of micro cracks.
{"title":"Effect of different thermal change tests of micro tensile strength behavior bio-composite materials; In vitro study","authors":"E. Yilmaz, R. Sadeler","doi":"10.4103/bmrj.bmrj_6_21","DOIUrl":"https://doi.org/10.4103/bmrj.bmrj_6_21","url":null,"abstract":"Background: The thermal changes in environments that composite materials are exposed to has a great effect on fatigue and wear behavior. Aim: Micro-cracks and interfacial deformations occur in the composite material structure because of heating and cooling environments occurring on material surfaces. Considering the environment to which bio-composite materials used in the human body are exposed, it is inevitable that they are exposed to a thermal change cycle environment. Material and Method: In this study, the mechanical behaviors of Silorane, X-Trafil and Valux-Plus bio-composite materials were examined after being exposed to thermal cycles in an artificial mouth environment in the temperature range of minimum 5 °C and maximum 65 °C. Micro-tensile strengths of bio-composite materials after thermal cycle test procedures were determined using a universal micro tensile tester device. In addition, microstructural analyzes of bio-composite materials were evaluated using scanning electron microscopy (SEM). Results: Within the scope of the data obtained as a result of this study, it was concluded that the thermal changes in environments significantly affects the micro-shrinkage behavior of bio-composite materials. Conclusion: The behavior of the matrix structure of the composite material significantly affected the formation of micro cracks.","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"20 1","pages":"14 - 19"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85711723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The presence of small quantities of genetically heterogeneous cells in an organism is known as microchimerism. Fetal microchimerism is the presence of small quantities of fetal cells in the maternal system during and after pregnancy. Since these cells are semi-allogeneic in the mother's body, they have an impact on the mother's health. Recent studies suggest contradictory outcomes. Some suggest an involvement in autoimmune diseases and cancer. Others suggest involvement in tissue repair and wound healing. Fetal cells have been detected in maternal organs decades after pregnancy. It was found that these cells participate in the healing process post a chronic injury. In other cases, these cells initiate an immune response which may lead to the development of autoimmune diseases. Further, studies show that fetal cells have been discovered in the tumor microenvironment, either aiding in cancer development or eradicating the cancer cells. Here, I review the different outcomes that can occur in the female body because of fetal cell microchimerism. I discuss the presence of fetal cells in maternal organs such as the heart and the central nervous system organs and their involvement in disease development and tissue repair in the mother.
{"title":"The outcomes of fetal cell microchimerism in the mother","authors":"A. Alekar","doi":"10.4103/bmrj.bmrj_9_21","DOIUrl":"https://doi.org/10.4103/bmrj.bmrj_9_21","url":null,"abstract":"The presence of small quantities of genetically heterogeneous cells in an organism is known as microchimerism. Fetal microchimerism is the presence of small quantities of fetal cells in the maternal system during and after pregnancy. Since these cells are semi-allogeneic in the mother's body, they have an impact on the mother's health. Recent studies suggest contradictory outcomes. Some suggest an involvement in autoimmune diseases and cancer. Others suggest involvement in tissue repair and wound healing. Fetal cells have been detected in maternal organs decades after pregnancy. It was found that these cells participate in the healing process post a chronic injury. In other cases, these cells initiate an immune response which may lead to the development of autoimmune diseases. Further, studies show that fetal cells have been discovered in the tumor microenvironment, either aiding in cancer development or eradicating the cancer cells. Here, I review the different outcomes that can occur in the female body because of fetal cell microchimerism. I discuss the presence of fetal cells in maternal organs such as the heart and the central nervous system organs and their involvement in disease development and tissue repair in the mother.","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"16 1","pages":"1 - 8"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86580702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mitochondrial DNA (mtDNA), as its name implies, is an embodiment of the mitochondrial genetic information that constitutes about 1% of the mammalian genome. It fills a vital niche in tracing matrilineality; the mtDNA is inherited solely from the mother and plays a crucial role in genealogical research. Even a single mutation in the mtDNA can have debilitating and life-altering consequences. Mothers carrying mtDNA mutations will inevitably pass it on to the future generation. Three-parent In vitro fertilization (IVF), a breakthrough technique, shows promising potential to prevent mothers with mtDNA defects from passing it on to their future generation, while also maintaining the genetic link to their posterity. In this review, I delve into the intricacies of this technique, compare and analyze the difference between maternal spindle transfer and pronuclear transfer, discuss the prospective therapeutic effects, and highlight the ethical concerns surrounding this procedure. Considering the various challenges and ethics of this contentious technique, the paper seeks to answer the rousing question – Is three-parent IVF the answer to preventing mitochondrial defects?
{"title":"Is three-parent IVF the answer to preventing mitochondrial defects?","authors":"Shloka Shetty","doi":"10.4103/bmrj.bmrj_10_21","DOIUrl":"https://doi.org/10.4103/bmrj.bmrj_10_21","url":null,"abstract":"Mitochondrial DNA (mtDNA), as its name implies, is an embodiment of the mitochondrial genetic information that constitutes about 1% of the mammalian genome. It fills a vital niche in tracing matrilineality; the mtDNA is inherited solely from the mother and plays a crucial role in genealogical research. Even a single mutation in the mtDNA can have debilitating and life-altering consequences. Mothers carrying mtDNA mutations will inevitably pass it on to the future generation. Three-parent In vitro fertilization (IVF), a breakthrough technique, shows promising potential to prevent mothers with mtDNA defects from passing it on to their future generation, while also maintaining the genetic link to their posterity. In this review, I delve into the intricacies of this technique, compare and analyze the difference between maternal spindle transfer and pronuclear transfer, discuss the prospective therapeutic effects, and highlight the ethical concerns surrounding this procedure. Considering the various challenges and ethics of this contentious technique, the paper seeks to answer the rousing question – Is three-parent IVF the answer to preventing mitochondrial defects?","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"26 1","pages":"9 - 13"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84518613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In the battle against cancer, timely diagnosis is critical for successful treatment. The major limitation in detecting cancer at early development stages is the unavailability of sensitive and specific detection methods. Nanobiology combines biology with physics and chemistry to generate several new areas such as nanodiagnostics and nanotheranostics. Nanodiagnostics involve the development of new strategies and innovations to enhance the current detection methods in tumor biology. Another important aspect of nanodiagnostics is to improve personalized cancer detection and real-time monitoring of treatments assisted by imaging modalities. Nanotheranostics combines therapy and diagnosis in a single model for cancer detection and treatment thus providing the advantage of targeted drug delivery and fewer side effects to normal tissues. In this review, we have outlined diverse nanoparticle systems for early cancer detection and therapy. A wide variety of nanomaterial-based approaches such as nanobubbles, quantum dots, liposomes, or nanotubes demonstrate huge potential in improving imaging methods to screen and monitor cancer progression. Although a significant amount of contributions have been directed to develop nanodiagnostics systems, they are still at preclinical stage. Thus, it is a dynamic area for research with encouraging development towards the clinical stage.
{"title":"An Overview on the Application of Nanodiagnostics in Cancer","authors":"Kavita Gala, Ekta Khattar","doi":"10.4103/bmrj.bmrj_14_20","DOIUrl":"https://doi.org/10.4103/bmrj.bmrj_14_20","url":null,"abstract":"In the battle against cancer, timely diagnosis is critical for successful treatment. The major limitation in detecting cancer at early development stages is the unavailability of sensitive and specific detection methods. Nanobiology combines biology with physics and chemistry to generate several new areas such as nanodiagnostics and nanotheranostics. Nanodiagnostics involve the development of new strategies and innovations to enhance the current detection methods in tumor biology. Another important aspect of nanodiagnostics is to improve personalized cancer detection and real-time monitoring of treatments assisted by imaging modalities. Nanotheranostics combines therapy and diagnosis in a single model for cancer detection and treatment thus providing the advantage of targeted drug delivery and fewer side effects to normal tissues. In this review, we have outlined diverse nanoparticle systems for early cancer detection and therapy. A wide variety of nanomaterial-based approaches such as nanobubbles, quantum dots, liposomes, or nanotubes demonstrate huge potential in improving imaging methods to screen and monitor cancer progression. Although a significant amount of contributions have been directed to develop nanodiagnostics systems, they are still at preclinical stage. Thus, it is a dynamic area for research with encouraging development towards the clinical stage.","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"1 1","pages":"40 - 44"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75595172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lots of research based on drug designing as well as in silico study, cell culture/animal model study, and the clinical trials are being conducted perceive the suitable therapeutic drugs and to develop vaccines in order to alleviate the ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2. Although there are still no vaccines, some potential antiviral drugs have been repurposed including remdesivir, chloroquine/hydroxychloroquine, ribavirin, favipiravir, cepharanthine, and lopinavir/ritonavir, of which remdesivir has been mostly accepted for the treatment purpose because of its multitarget actions. Besides, the immunosuppressive agent, dexamethasone, evolved with the capacity to protect the severely affected COVID-19 patients from death to some extent. The current review, thus, emphasized on both remdesivir and dexamethasone as the successful remedies for the ongoing pandemic and detected the possible mode of action of dexamethasone.
{"title":"Remdesivir and Dexamethasone: The Two Eligible Candidate Drugs Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) Infection","authors":"Y. Sikandar, Ilora Kheya, R. Noor","doi":"10.4103/BMRJ.BMRJ_10_20","DOIUrl":"https://doi.org/10.4103/BMRJ.BMRJ_10_20","url":null,"abstract":"Lots of research based on drug designing as well as in silico study, cell culture/animal model study, and the clinical trials are being conducted perceive the suitable therapeutic drugs and to develop vaccines in order to alleviate the ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2. Although there are still no vaccines, some potential antiviral drugs have been repurposed including remdesivir, chloroquine/hydroxychloroquine, ribavirin, favipiravir, cepharanthine, and lopinavir/ritonavir, of which remdesivir has been mostly accepted for the treatment purpose because of its multitarget actions. Besides, the immunosuppressive agent, dexamethasone, evolved with the capacity to protect the severely affected COVID-19 patients from death to some extent. The current review, thus, emphasized on both remdesivir and dexamethasone as the successful remedies for the ongoing pandemic and detected the possible mode of action of dexamethasone.","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"1 1","pages":"29 - 33"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89860163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Doctors' role in care is changing to the extent that their responsibility now includes not only preserving life and its quality but extends to end of life care as well. Patients -are now asking for more autonomy in choosing the how and when of end of life care and processes. Doctors have different opinions regarding these methods of assisted death , and these opinions are determined by various personal and professional factors. Indian literature regarding the influence of career stage on doctors' approach to assisted death is scanty and our project aimed to assess this influence, as well as find the reasons for favouring or not favouing the various modalities of assisted death. Materials and Methods: In this study, a prevalidated, piloted questionnaire regarding the different types of assisted death was administered by the interviewer to professors, associate professors, assistant professors, senior residents and post graduate residents of a medical college. Results: Post graduate residents, senior residents and Assistant professors opined that Legalization of DNR, Physician assisted suicide and euthanasia might be acceptable under certain circumstances. Reasons for favouring assisted death included medical futility and patient suffering. Those who opposed assisted death did so on the grounds of medical ethics and humanity. Conclusion: Junior cadres tended to be more accepting of assisted death than their more senior colleagues.
{"title":"Doctors' Perception of Assisted Death: The Effect of Career Stage","authors":"Smitha S. Bhat","doi":"10.4103/BMRJ.BMRJ_11_20","DOIUrl":"https://doi.org/10.4103/BMRJ.BMRJ_11_20","url":null,"abstract":"Introduction: Doctors' role in care is changing to the extent that their responsibility now includes not only preserving life and its quality but extends to end of life care as well. Patients -are now asking for more autonomy in choosing the how and when of end of life care and processes. Doctors have different opinions regarding these methods of assisted death , and these opinions are determined by various personal and professional factors. Indian literature regarding the influence of career stage on doctors' approach to assisted death is scanty and our project aimed to assess this influence, as well as find the reasons for favouring or not favouing the various modalities of assisted death. Materials and Methods: In this study, a prevalidated, piloted questionnaire regarding the different types of assisted death was administered by the interviewer to professors, associate professors, assistant professors, senior residents and post graduate residents of a medical college. Results: Post graduate residents, senior residents and Assistant professors opined that Legalization of DNR, Physician assisted suicide and euthanasia might be acceptable under certain circumstances. Reasons for favouring assisted death included medical futility and patient suffering. Those who opposed assisted death did so on the grounds of medical ethics and humanity. Conclusion: Junior cadres tended to be more accepting of assisted death than their more senior colleagues.","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"9 1","pages":"55 - 59"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73215892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Therapeutic Uses of Monoclonal Antibodies for COVID-19","authors":"Tarun Kumar Suvvari","doi":"10.4103/bmrj.bmrj_15_20","DOIUrl":"https://doi.org/10.4103/bmrj.bmrj_15_20","url":null,"abstract":"","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"21 1","pages":"60 - 61"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85258212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-02-01DOI: 10.4103/2349-3666.305772
{"title":"Erratum: Molecular Docking Study for Evaluation of Neuroprotective Potential of Sericin against Cerebral Stroke and Exploring Its Biomaterial Properties","authors":"","doi":"10.4103/2349-3666.305772","DOIUrl":"https://doi.org/10.4103/2349-3666.305772","url":null,"abstract":"","PeriodicalId":34293,"journal":{"name":"Biomedical Research Journal","volume":"18 1","pages":"62 - 62"},"PeriodicalIF":0.0,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73404503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：